Bortezomib + Lenalidomide + Dexamethasone

DRUG2 trials

Sponsors

Tanta University, Universitätsklinikum Hamburg-Eppendorf

Conditions

Multiple Myeloma, NeoplasmsMyelomaMyeloma MultiplePeripheral Neuropathy

Phase 1

Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma

Not yet recruitingNCT07600151

Universitätsklinikum Hamburg-EppendorfMyeloma Multiple, Myeloma

Start: 2026-12-01End: 2036-12-31Target: 220Updated: 2026-05-20

Phase 4

Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)

RecruitingNCT07025005

Tanta UniversityPeripheral Neuropathy, Multiple Myeloma, Neoplasms

Start: 2025-08-30End: 2026-09-30Target: 44Updated: 2025-11-04